Tandospirone

DB12833InvestigationalSmall molecule

Tandospirone has been used in trials studying the treatment of Schizophrenia.

Chemical structure of Tandospirone
Mechanism
Curator reviewed
Formula / weight
C21H29N5O2 · 383.496 g/mol (avg)

Resolves to

Compound
UNII190230I669CAS87760-53-0ChEMBLCHEMBL274047ChEBI145673PubChem91273
Structure
InChIKeyCEIJFEGBUDEYSX-FZDBZEDMSA-NSMILES[H][C@]12CC[C@]([H])(C1)[C@]1([H])C(=O)N(CCCCN3CCN(CC3)C3=NC=CC=N3)C(=O)[C@]21[H]
Targets
P08908HTR1A

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
708Drug interactionsStructured to mechanism, not free text
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Tandospirone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In